You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Drugs

The drug library provides access to information on over 100 cancer drugs available for use in Canada.

Displaying Drugs List

28 Items
Other Name(s): Avastin® (Hoffmann-LaRoche)
Funding:
New Drug Funding Program
  • Bevacizumab - Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
  • Bevacizumab in combination with paclitaxel and carboplatin - Front-line Treatment Ovarian Fallopian Tube and Primary Peritoneal Cancer
  • Bevacizumab - First Line - Metastatic Colorectal Small Bowel or Appendiceal Cancer
  • Bevacizumab for Platinum-Resistant Recurrent Ovarian Fallopian Tube or Primary Peritoneal Cancer
Nov 2017
Other Name(s): Blenoxane® (multiple brands available)
Aug 2016
Other Name(s): Paraplatin AQ® (multiple brands available)
Aug 2016
Other Name(s): Platinol AQ® (multiple brands available)
Aug 2016
Other Name(s): Procytox® (Baxter)
Funding:
ODB - General Benefit
  • cyclophosphamide - oral tablets
Nov 2017
Other Name(s): Cosmegen® (Recordati)
May 2016
Other Name(s): Taxotere® (multiple brands available)
Funding:
New Drug Funding Program
  • Docetaxel - Metastatic Castration-Resistant Prostate Cancer
  • Docetaxel - Non-Small Cell Lung Cancer (NSCLC)
  • Docetaxel - Non-Small Cell Lung Cancer (Second or Subsequent Line)
  • Docetaxel - Neoadjuvant treatment for Non-Metastatic Breast Cancer
  • Docetaxel - Metastatic Breast Cancer
  • Docetaxel - Hormone Sensitive Prostate Cancer
  • Trastuzumab with First Line Docetaxel - Metastatic Breast Cancer
  • Docetaxel - CYCLDOCE for Early Operable Breast Cancer
  • Docetaxel - FEC-D or AC-DOCE for Adjuvant Treatment for Breast Cancer
Nov 2017
Other Name(s): Adriamycin PFS® (multiple brands available)
Nov 2017
Other Name(s): Tarceva® (Hoffmann-LaRoche)
Funding:
Exceptional Access Program
  • erlotinib - Incurable progressive NSCLC, with specific criteria
May 2017
Other Name(s): Vepesid® (multiple brands available)
Funding:
ODB - General Benefit
  • etoposide - oral capsules
Nov 2017
Other Name(s): Adrucil® (multiple brands available); Efudex® Cream (Valeant)
Aug 2016
Other Name(s): Gemzar® (multiple brands available)
Funding:
New Drug Funding Program
  • Gemcitabine - Carcinoma of Bladder or Urothelium
  • Gemcitabine - Non-Small Cell Lung Cancer (NSCLC)
  • Gemcitabine - Advanced Pancreatic Cancer
Updated
Feb 2018